SEI Investments’s Relay Therapeutics RLAY Stock Holding History

SEI Investments’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480K	Sell	25,630 -10,500	-29%	-$152K	﹤0.01%	2658
2026 Q1	$359K	Buy	36,130 +10,500	+41%	+$93.9K	﹤0.01%	2765
2025 Q4	$217K	Hold	25,630	–	–	﹤0.01%	2871
2025 Q3	$134K	Hold	25,630	–	–	﹤0.01%	2683
2025 Q2	$88.7K	Hold	25,630	–	–	﹤0.01%	2695
2025 Q1	$67.2K	Buy	+25,630	New	+$100K	﹤0.01%	2656
2024 Q2	–	Sell	-10,692	Closed	-$88.7K	–	2715
2024 Q1	$88.7K	Sell	10,692 -4,629	-30%	-$45.2K	﹤0.01%	2515
2023 Q4	$169K	Buy	15,321 +2,405	+19%	+$20.3K	﹤0.01%	2461
2023 Q3	$109K	Sell	12,916 -398	-3%	-$4.28K	﹤0.01%	2507
2023 Q2	$167K	Sell	13,314 -5,553	-29%	-$69.1K	﹤0.01%	2496
2023 Q1	$311K	Buy	+18,867	New	+$338K	﹤0.01%	2323
2022 Q4	–	Sell	-15,630	Closed	-$350K	–	2655
2022 Q3	$350K	Buy	15,630 +3,307	+27%	+$72.6K	﹤0.01%	2247
2022 Q2	$204K	Buy	+12,323	New	+$264K	﹤0.01%	2469

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

SEI Investments's RLAY Position: Q2 2026 in Review

SEI Investments reduced its Relay Therapeutics (RLAY) stake by 29% in Q2 2026, selling an estimated $152K and leaving 25,630 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.

SEI Investments first reported a position in RLAY in Q2 2022 and has held it in 13 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

SEI Investments held 25,630 shares of Relay Therapeutics worth $480K as of Q2 2026.
SEI Investments sold 10,500 Relay Therapeutics shares in Q2 2026, an estimated $152K.
Relay Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2658 holding.
SEI Investments first reported a position in Relay Therapeutics in Q2 2022 and has held it in 13 quarters since.
259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.